Jul. 4 at 4:54 AM
$KLTO 🚨 KLTO: Orphan Drug Designation Confirmed 🚨
🧬 A powerful FDA status — extremely rare for microcaps — just landed for KLTO.
✅ 7 YEARS of market exclusivity
✅ Massive tax benefits
✅ Target: Dementia with Lewy Bodies – a severe, underserved condition
---
🔒 But here’s the twist...
The company hasn't officially announced it yet.
Why? Simple:
🗓️ The news dropped just before the holiday – and they’re clearly holding it for next week’s market open.
💣 When they do — it’s game on.
---
🧨 Meanwhile, shorts are loading up…
They think
$1.10 is expensive?
They forgot KLTO ran to
$3.50 on lesser news
This time it’s FDA-approved firepower — and institutions will be watching 👀
---
📈 Summary:
🔹 Rare FDA designation for a tiny biotech
🔹 Still not officially announced — but confirmed
🔹 Institutions will jump in
🔹 Short squeeze + formal PR = 🚀🚀🚀
---
The countdown is ticking.
The PR is coming.
The squeeze is inevitable.
💥 Enjoy the fireworks.
